JP2019532105A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532105A5
JP2019532105A5 JP2019541893A JP2019541893A JP2019532105A5 JP 2019532105 A5 JP2019532105 A5 JP 2019532105A5 JP 2019541893 A JP2019541893 A JP 2019541893A JP 2019541893 A JP2019541893 A JP 2019541893A JP 2019532105 A5 JP2019532105 A5 JP 2019532105A5
Authority
JP
Japan
Prior art keywords
fluid
dry eye
severe dry
surgery
treating severe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019541893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019532105A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/001364 external-priority patent/WO2018069763A1/en
Publication of JP2019532105A publication Critical patent/JP2019532105A/ja
Publication of JP2019532105A5 publication Critical patent/JP2019532105A5/ja
Priority to JP2022122165A priority Critical patent/JP2022153583A/ja
Pending legal-status Critical Current

Links

JP2019541893A 2016-10-14 2017-10-02 角結膜のホメオスタシスを確立、回復及び維持するための方法 Pending JP2019532105A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022122165A JP2022153583A (ja) 2016-10-14 2022-07-29 角結膜のホメオスタシスを確立、回復及び維持するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662408559P 2016-10-14 2016-10-14
US62/408,559 2016-10-14
US201762516911P 2017-06-08 2017-06-08
US62/516,911 2017-06-08
PCT/IB2017/001364 WO2018069763A1 (en) 2016-10-14 2017-10-02 Method for establishing, restoring, and preserving homeostasis of the ocular surface

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022122165A Division JP2022153583A (ja) 2016-10-14 2022-07-29 角結膜のホメオスタシスを確立、回復及び維持するための方法

Publications (2)

Publication Number Publication Date
JP2019532105A JP2019532105A (ja) 2019-11-07
JP2019532105A5 true JP2019532105A5 (ru) 2020-11-12

Family

ID=60766004

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019541893A Pending JP2019532105A (ja) 2016-10-14 2017-10-02 角結膜のホメオスタシスを確立、回復及び維持するための方法
JP2022122165A Pending JP2022153583A (ja) 2016-10-14 2022-07-29 角結膜のホメオスタシスを確立、回復及び維持するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022122165A Pending JP2022153583A (ja) 2016-10-14 2022-07-29 角結膜のホメオスタシスを確立、回復及び維持するための方法

Country Status (8)

Country Link
US (1) US20190240251A1 (ru)
EP (2) EP3871682A1 (ru)
JP (2) JP2019532105A (ru)
KR (1) KR20190068575A (ru)
ES (1) ES2909998T3 (ru)
HU (1) HUE058672T2 (ru)
PL (1) PL3525799T3 (ru)
WO (1) WO2018069763A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190068575A (ko) 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
EP3781175A1 (en) * 2018-04-18 2021-02-24 i.com Medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
CN112714644B (zh) * 2018-09-20 2024-03-29 香港科技大学 滴眼剂组合物
US20210369764A1 (en) * 2019-01-31 2021-12-02 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
EP4106772A1 (en) * 2020-06-12 2022-12-28 i.com Medical GmbH High molecular weight hyaluronic acid for use in the treatment of corneal nerve damage or loss
US20230338541A1 (en) * 2020-06-21 2023-10-26 i.com medical GmbH Use of high molecular weight hyaluronic acid as ocular transporting vehicle
WO2023240155A1 (en) * 2022-06-08 2023-12-14 The Schepens Eye Research Institute, Inc. Methods for treating dry eye disease

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
JP3050898B2 (ja) * 1990-07-06 2000-06-12 千寿製薬株式会社 水性医薬製剤
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
EP1142566B1 (fr) * 2000-04-07 2003-10-01 Laboratoire Medidom S.A. Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
US6528464B1 (en) * 2001-08-17 2003-03-04 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
JP3779200B2 (ja) * 2001-11-28 2006-05-24 電気化学工業株式会社 ヒアルロン酸及び/又はその塩の水溶液の安定化組成物
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
CN103638040A (zh) * 2002-07-03 2014-03-19 派瑞克科学公司 透明质酸组合物以及使用方法
DE10360425A1 (de) 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
WO2007043702A1 (en) * 2005-10-12 2007-04-19 Seikagaku Corporation Agent for applying to mucosa and method for production thereof
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
EP2187900B1 (en) * 2007-08-16 2016-11-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
US20110065642A1 (en) * 2008-05-15 2011-03-17 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
JP5595206B2 (ja) * 2009-09-30 2014-09-24 ロート製薬株式会社 眼科用液体組成物
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
CN103221422B (zh) * 2010-07-29 2017-03-29 十一生物治疗股份有限公司 嵌合il‑1受体i型激动剂和拮抗剂
AU2011299851A1 (en) * 2010-09-10 2013-04-04 Santen Pharmaceutical Co., Ltd. Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof
EP3226853B1 (en) * 2014-12-02 2019-09-04 Regeneron Pharmaceuticals, Inc. Animal model for dry eye and methods of use of such animals
JP6716293B2 (ja) * 2015-03-06 2020-07-01 参天製薬株式会社 眼科用組成物
US20170014339A1 (en) 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
KR20190068575A (ko) 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법

Similar Documents

Publication Publication Date Title
JP2019532105A5 (ru)
US20210401789A1 (en) Ophthalmic compositions and methods for treating eyes
CN111991415B (zh) 一种眼部护理组合物及其制备方法和用途
CN101312711B (zh) 不含右泛醇、钙离子和磷酸盐的药物组合物以及钙螯合剂和眼科相容粘度调节剂的应用
US20070141091A1 (en) Biguanide ointment and method of treatment and prevention of infections
CN103037858A (zh) 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物
US7820639B2 (en) Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
US10279046B2 (en) Eye drop composition for treating ocular inflammatory disease and preparation method therefor
WO2021101883A1 (en) Chitosan containing compositions and methods relating to same
KR101723703B1 (ko) 안구 통증을 치료 또는 예방하기 위한 케토롤락 트로메타민 조성물
JP2008189677A (ja) 洗浄剤
WO2020140365A1 (zh) 一种含有黄原胶的保湿润滑组合物及其应用
US9233123B1 (en) Use of ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan
US20190151352A1 (en) Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof
JP5957517B2 (ja) 結膜弛緩症治療用の点眼薬
US8551974B1 (en) Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
JP2023038930A (ja) 眼表面薬物滞留化剤およびこれを含む点眼剤、並びに、これらの剤を用いた眼表面薬物滞留方法および眼科疾患治療方法
KR20220008720A (ko) 카라기난을 포함하는 점안용 조성물
JP2004043516A (ja) 眼科用剤